Shares of weight-loss drugmakers Novo Nordisk (NVO) and Eli Lilly (NYSE ... with established cardiovascular disease. In ...

GLP-1 drugs such as Wegovy and Zepbound are growing increasingly prominent. But some food ingredients can also cause the body ...

Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

A radical shifting of trade flows has given Ireland the second-biggest trade imbalance with the U.S. after China, mostly due to demand for weight-loss drugs.